Filing Details

Accession Number:
0000950170-24-109731
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-26 20:34:13
Reporting Period:
2024-09-24
Accepted Time:
2024-09-26 20:34:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1635088 Roivant Sciences Ltd. ROIV Pharmaceutical Preparations (2834) 981173944
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1832142 Allen Daniel Gold C/O Roivant Sciences Ltd.
7Th Floor, 50 Broadway
London X0 SW1H 0DB
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2024-09-24 1,565,670 $11.63 5,723,423 No 4 S Direct
Common Shares Disposition 2024-09-24 577,186 $11.63 2,079,059 No 4 S Indirect Held by trusts and estate planning vehicles established by the Reporting Person
Common Shares Disposition 2024-09-25 991,593 $11.77 4,731,830 No 4 S Direct
Common Shares Disposition 2024-09-25 365,551 $11.77 1,713,508 No 4 S Indirect Held by trusts and estate planning vehicles established by the Reporting Person
Common Shares Disposition 2024-09-25 50,000 $11.77 23,055,358 No 4 S Indirect Held by QVT Financial Investment Cayman Ltd.
Common Shares Disposition 2024-09-26 876,000 $11.82 22,179,358 No 4 S Indirect Held by QVT Financial Investment Cayman Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect Held by trusts and estate planning vehicles established by the Reporting Person
No 4 S Direct
No 4 S Indirect Held by trusts and estate planning vehicles established by the Reporting Person
No 4 S Indirect Held by QVT Financial Investment Cayman Ltd.
No 4 S Indirect Held by QVT Financial Investment Cayman Ltd.
Footnotes
  1. The reporting person is a trustee of trusts and estate planning vehicles, each of which were formed by the reporting person and/or his immediate family members, and shares voting and investment control over the Common Shares held directly by these trusts and may be deemed to beneficially own such Common Shares. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
  2. The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.